SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-108454
Filing Date
2024-04-24
Accepted
2024-04-24 07:30:28
Documents
4
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d820524ddef14a.htm DEF 14A 431868
2 GRAPHIC g820524dsp013.jpg GRAPHIC 163513
3 GRAPHIC g820524dsp014.jpg GRAPHIC 297778
4 GRAPHIC g820524g55k19.jpg GRAPHIC 71024
  Complete submission text file 0001193125-24-108454.txt   1166693
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38452 | Film No.: 24866724
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)